Journal of Thoracic Oncology

Wolters Kluwer Health Logo

Login
Register
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	Current Issue	Previous Issues	Published Ahead-of-Print	For Authors	Journal Info

About the Journal

Editorial Board

Advertising

Subscription Services

Reprints

Job Opportunities

Rights and Permissions

Mobile

Home > June 2008 - Volume 3 - Issue 6

June 2008 - Volume 3 - Supplement 2 6

pp: S107-S178

Table of Contents Sections

Download TOC to PDA

View Contributor Index

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at Journal of Thoracic Oncology.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Select All | Hide Details

Novel Agents in the Treatment of Lung Cancer

Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy

Lynch, Thomas J. Jr; Blumenschein, George R. Jr; Engelman, Jeffrey A.; Espinoza-Delgado, Igor; Govindan, Ramaswamy; Hanke, Jeff; Hanna, Nasser H.; Heymach, John V.; Hirsch, Fred R.; Janne, Pasi A.; Lilenbaum, Rogerio C.; Natale, Ronald B.; Riely, Gregory J.; Sequist, Lecia V.; Shapiro, Geoffrey I.; Shaw, Alice; Shepherd, Frances A.; Socinski, Mark; Sorensen, A Gregory; Wakelee, Heather A.; Weitzman, Aaron

Journal of Thoracic Oncology. 3(6):S107-S112, June 2008.

doi: 10.1097/JTO.0b013e318174e9d3

Abstract:

Go to Full Text of this Article

Antibodies to Vascular Endothelial Growth Factor in Non-small Cell Lung Cancer

Wakelee, Heather

Journal of Thoracic Oncology. 3(6):S113-S118, June 2008.

doi: 10.1097/JTO.0b013e318174e993

Abstract:

Go to Full Text of this Article

The Current Status and Evolving Role of Sunitinib in Non-small Cell Lung Cancer

Socinski, Mark A.

Journal of Thoracic Oncology. 3(6):S119-S123, June 2008.

doi: 10.1097/JTO.0b013e318174e9be

Abstract:

Go to Full Text of this Article

Sorafenib in Lung Cancer: Clinical Developments and Future Directions

Blumenschein, George Jr

Journal of Thoracic Oncology. 3(6):S124-S127, June 2008.

doi: 10.1097/JTO.0b013e318174e085

Abstract:

Go to Full Text of this Article

Dual Targeting of the Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Pathways with Vandetinib (ZD6474) in Patients with Advanced or Metastatic Non-small Cell Lung Cancer

Natale, Ronald B.

Journal of Thoracic Oncology. 3(6):S128-S130, June 2008.

doi: 10.1097/JTO.0b013e318174e95a

Abstract:

Go to Full Text of this Article

The Tyrosine Kinase Inhibitor Cediranib for Non-small Cell Lung Cancer and Other Thoracic Malignancies

Nikolinakos, Petros; Heymach, John V.

Journal of Thoracic Oncology. 3(6):S131-S134, June 2008.

doi: 10.1097/JTO.0b013e318174e910

Abstract:

Go to Full Text of this Article

Discussion - Anti-Vegf Agents

Journal of Thoracic Oncology. 3(6):S135-S137, June 2008.

doi: 10.1097/JTO.0b013e318174e9e6

First-Generation Epidermal Growth Factor Receptor Inhibitors in Non-small Cell Lung Cancer: Clinical Impact of the Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization Assay

Hirsch, Fred R.; Dziadziuszko, Rafal; Varella-Garcia, Marileila; Franklin, Wilbur A.; Gandara, David R.; Bunn, Paul A. Jr

Journal of Thoracic Oncology. 3(6):S138-S142, June 2008.

doi: 10.1097/JTO.0b013e318174e922

Abstract:

Go to Full Text of this Article

First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation: Positive Non-small Cell Lung Cancer Patients

Sequist, Lecia V.

Journal of Thoracic Oncology. 3(6):S143-S145, June 2008.

doi: 10.1097/JTO.0b013e318174e981

Abstract:

Go to Full Text of this Article

Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer

Riely, Gregory J.

Journal of Thoracic Oncology. 3(6):S146-S149, June 2008.

doi: 10.1097/JTO.0b013e318174e96e

Abstract:

Go to Full Text of this Article

Discussion - Egfr-Targeted Agents

Journal of Thoracic Oncology. 3(6):S150-S151, June 2008.

doi: 10.1097/JTO.0b013e318174e9f6

Heat Shock Protein 90 Inhibition in Lung Cancer

Shimamura, Takeshi; Shapiro, Geoffrey I.

Journal of Thoracic Oncology. 3(6):S152-S159, June 2008.

doi: 10.1097/JTO.0b013e318174ea3a

Abstract:

Go to Full Text of this Article

K-ras as a Target for Lung Cancer Therapy

Adjei, Alex A.

Journal of Thoracic Oncology. 3(6):S160-S163, June 2008.

doi: 10.1097/JTO.0b013e318174dbf9

Abstract:

Go to Full Text of this Article

Immunotherapy for Lung Cancer

Bradbury, Penelope A.; Shepherd, Frances A.

Journal of Thoracic Oncology. 3(6):S164-S170, June 2008.

doi: 10.1097/JTO.0b013e318174e9a7

Abstract:

Go to Full Text of this Article

New Horizons in Chemotherapy: Platforms for Combinations in First-Line Advanced Non-small Cell Lung Cancer

Lilenbaum, Rogerio C.

Journal of Thoracic Oncology. 3(6):S171-S174, June 2008.

doi: 10.1097/JTO.0b013e318174e942

Abstract:

Go to Full Text of this Article

Discussion - Other Lung Cancer Targets

Journal of Thoracic Oncology. 3(6):S175, June 2008.

doi: 10.1097/JTO.0b013e318174ea08

Discussion - Clinical Trials and Combination Therapies in Lung Cancer

Journal of Thoracic Oncology. 3(6):S176-S178, June 2008.

doi: 10.1097/JTO.0b013e318174ea18

Table of Contents Outline | Back to Top

Table of Contents Sections

Novel Agents in the Treatment of Lung Cancer

Select All

Advertisement

Copyright © 2010
Lippincott Williams & Wilkins
All rights reserved.

Privacy Policy
Terms of Use
NIH Public Access Policy

Feedback